Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enteric immunization: promises and challenges

W R Brown1

  • 1Denver Veterans Administration Medical Center, CO, USA.

Digestive Diseases (Basel, Switzerland)
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased cytoplasmic accumulation of goblet cell glycoproteins in ulcerative colitis.

Inflammatory bowel diseases·2013
Same author

Review: cerebral microvascular pathology in ageing and neurodegeneration.

Neuropathology and applied neurobiology·2010
Same author

Pneumoperitoneum in the Treatment of Pulmonary Tuberculosis.

Journal of the National Medical Association·2010
Same author

The piglet as a model for B cell and immune system development.

Veterinary immunology and immunopathology·2008
Same author

A morphologic study of the vasculature of malignant gliomas using thick celloidin sections and alkaline phosphatase stain.

Clinical neuropathology·2004
Same author

A three-dimensional study of brain string vessels using celloidin sections stained with anti-collagen antibodies.

Journal of the neurological sciences·2002
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Oral immunization strategies are being developed to overcome the limitations of parenteral vaccines in preventing intestinal infections. Promising methods include microparticle delivery, genetic modification of microbes, and mucosal adjuvants for enhanced enteric protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Gastroenterology

Background:

  • Parenteral vaccines poorly stimulate the intestinal immune system, limiting their effectiveness against enteric infections.
  • Intestinal infections remain a significant global health burden, particularly diarrheal diseases.

Purpose of the Study:

  • To review and highlight promising strategies for effective oral immunization against intestinal infections.
  • To address the inadequacy of current parenteral vaccination routes for inducing intestinal immunity.

Main Methods:

  • Discusses the incorporation of immunogens into protective microparticles for enhanced uptake by intestinal lymphoid tissues.
  • Explores the genetic manipulation of microorganisms as a delivery vehicle for oral vaccines.
  • Highlights the use of mucosal adjuvants to boost immune responses in the gut.

Related Experiment Videos

Main Results:

  • Microparticle-based oral vaccines show potential for improved immunogen delivery and uptake.
  • Genetically modified microorganisms offer a novel approach to oral vaccine development.
  • Mucosal adjuvants can enhance the efficacy of oral immunization strategies.

Conclusions:

  • Effective oral immunization is crucial for controlling widespread diarrheal illnesses.
  • Advancements in microparticle technology, microbial genetics, and mucosal adjuvants pave the way for improved intestinal vaccines.